REGULATION OF PHAGOCYTOSIS
REGULATION OF PHAGOCYTOSIS
批准号:
6380580
负责人:
JAMES CARDELLI
金额:
$18.53万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-01-01 至 2003-06-30
关键词:
Dictyostelium cell fusion confocal scanning microscopy electron microscopy enzyme activity enzyme inhibitors fluorescence microscopy guanosinetriphosphatases immunoelectron microscopy light microscopy lysosomes membrane permeability molecular cloning phagocytosis phosphatidylinositol 3 kinase protein kinase protein structure function protein transport site directed mutagenesis transmission electron microscopy yeast two hybrid system
中文摘要
白细胞对微生物的吞噬是第一个重要的
在预防全身性感染方面的定义。吞噬小体
含有病原体的生物通常通过一系列的融合而被修饰
和裂解反应,涉及内切溶酶体的隔室
系统,这导致了敌意中的有机体的破坏
吞噬溶酶体的环境。许多病原体,包括致病原
结核病(分枝杆菌)的作用,已经进化出预防机制
吞噬小体到吞噬溶酶体的成熟,从而允许它们的
生死存亡。关于生物化学机制,人们知之甚少
调节裂变和融合反应,调节吞噬小体成熟,
尽管有人假设Rab家族的小G蛋白
磷脂酰肌醇3-激酶(PI-3-Kinase)起着重要作用。
鉴于世界范围内传染性疾病发病率的显著增加
疾病,了解生化机制是至关重要的。
调节吞噬成熟以发展类固醇治疗
接近了。
调节吞噬作用的机制目前正在研究中
遗传上易驯化的阿米巴,盘基网眼菌。这些研究
揭示了吞噬小体成熟的至少4个阶段,包括
形成包含多个颗粒的宽敞的吞噬小体是一个过程
被许多细胞内病原体利用。遗传和生化
已有方法被用来确定GPTase、Rab7和PI 3-
激酶DdPIK1和DdPIK2似乎调节了这一过程。此外,
一种新的Rab,Rabb,也在人类细胞中发现,调节吞噬作用。至
确定调节吞噬小体的生化机制
为使之成熟,提出了以下具体目标。在具体目标1中,
遗传和生化方法将被用来:1)确定PI 3-
蛋白激酶直接作用于吞噬体膜中的磷脂。
以调节同型融合;2)确定Rab7和PI3-Kinase是否
功能偶联;3)鉴定Rab7效应蛋白。具体而言
目的#2,兔在调节中的生化作用机制
吞噬作用和吞噬小体成熟将得到更好的界定。结果是
这些研究应该为以下重要问题提供答案
问题:1)Rab7和PI3-Kinase在功能上和物理上
相互作用:2)PI-激酶和Rab7是否调节细胞内的其他步骤
吞噬小体成熟途径,除了同型融合:3)什么是
与Rab7相互作用的效应蛋白的生化性质;
4)Rabb如何调节粒子的内化?5)如何
Rabb在吞噬小体途径中的其他功能吗?
英文摘要
Phagocytosis of microorganisms by leukocytes represents an important first
line of define in the prevention of systemic infections. Phagosomes
containing pathogenic organisms are usually modified by a series of fusion
and fission reactions, involving compartments of the endo-lysosomal
system, which results in the destruction of the organism in the hostile
milieu of the phago-lysosome. Many pathogens, including the causative
effect of tuberculosis (Mycobacteria), have evolved mechanisms to prevent
the maturations of phagosomes to phago-lysosomes, thus allowing for their
survival. Little is known concerning the biochemical mechanisms that
regulate the fission and fusion reactions regulation phagosome maturation,
although it has been hypothesized that the Rab family of small G proteins
are phosphatidylinositide 3-kinases (PI 3-kinases) play an important role.
Given the significant increase world-wide in the incidence of infectious
diseases, it is critical to understand the biochemical mechanisms
regulating phagocytosis maturation in order to develop ratione therapeutic
approaches.
The mechanism regulating phagocytosis are currently being investigated in
the genetically tractable amoeba, Dictyostelium discoideum. These studies
have revealed at least 4 stages in phagosomal maturation, including the
formation of spacious phagosomes containing multiple particles, a process
exploited by many intracellular pathogens. Genetic and biochemical
approaches have been used to determine that a GPTase, Rab7, and the PI 3-
kinases, DdPIK1 and DdPIK2, appear to regulated this process. Furthermore,
a novel Rab, RabB, also found in humans cells, regulated phagocytosis. To
determine the biochemical mechanisms that operate to regulate phagosomal
maturation, the following specific aims are proposed. In specific aim#1,
genetic and biochemical approaches will be used to: 1) determine if PI 3-
kinases act directly by phosphorylating lipids in the phagosome membrane
to regulate homotypic fusion; 2) determine if Rab7 and PI 3-kinases are
functionally coupled and 3) identify Rab7 effector proteins. In specific
aim #2, the biochemical mechanisms of action of RabB in regulating
phagocytosis and phagosomal maturation will be better defined. The results
from these studies should supply answers to the following important
questions: 1) do Rab7 and PI 3-kinase functionally and physically
interact: 2) do PI-kinases and Rab7 regulated other steps in the
phagosomal maturation pathway, in addition to homotypic fusion: 3) what is
the biochemical nature of the effector proteins that interact with Rab7;
4) how does RabB regulate internalization of particles and 5) how does
RabB function elsewhere in the phagosomal pathway?
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1083/jcb.136.6.1271
发表时间:
1997-03-24
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Buczynski G, Grove B, Nomura A, Kleve M, Bush J, Firtel RA, Cardelli J]
通讯作者:
Cardelli J
Molecular cloning and DNA sequence of a Dictyostelium cDNA encoding a Ran/TC4 related GTP binding protein belonging to the ras superfamily.
编码属于 ras 超家族的 Ran/TC4 相关 GTP 结合蛋白的盘基网柄菌 cDNA 的分子克隆和 DNA 序列。
DOI:
10.1093/nar/21.7.1675
发表时间:
1993
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Bush,J, Cardelli,J]
通讯作者:
Cardelli,J
Inhibition of early but not late proteolytic processing events leads to the missorting and oversecretion of precursor forms of lysosomal enzymes in Dictyostelium discoideum.
抑制早期但非晚期蛋白水解加工事件会导致盘基网柄菌中溶酶体酶前体形式的错误分选和过度分泌。
DOI:
10.1083/jcb.107.6.2097
发表时间:
1988
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Richardson,JM, Woychik,NA, Ebert,DL, Dimond,RL, Cardelli,JA]
通讯作者:
Cardelli,JA
DOI:
10.1083/jcb.126.2.343
发表时间:
1994-07
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Ruscetti T, Cardelli JA, Niswonger ML, O'Halloran TJ]
通讯作者:
O'Halloran TJ
Early and late endosomal compartments of Entamoeba histolytica are enriched in cysteine proteases, acid phosphatase and several Ras-related Rab GTPases.
溶组织内阿米巴的早期和晚期内体区室富含半胱氨酸蛋白酶、酸性磷酸酶和几种 Ras 相关的 Rab GTP 酶。
DOI:
10.1016/s0166-6851(99)00133-4
发表时间:
1999
期刊:
Molecular and biochemical parasitology
影响因子:
1.5
作者:
[Temesvari,LA, Harris,EN, StanleyJr,SL, Cardelli,JA]
通讯作者:
Cardelli,JA
共 29 条
Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease
-
批准号:10814086
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2019
-
负责人:JAMES CARDELLI
-
依托单位:
Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease
-
批准号:10482506
-
项目类别:
-
资助金额:$169.24万
-
财政年份:2019
-
负责人:JAMES CARDELLI
-
依托单位:
Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease
-
批准号:10701764
-
项目类别:
-
资助金额:$80.58万
-
财政年份:2019
-
负责人:JAMES CARDELLI
-
依托单位:
IFN-gamma Induced Macrophage GTPases in Brucella Killing
-
批准号:7078828
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2006
-
负责人:JAMES CARDELLI
-
依托单位:
Role of IFN-gamma Induced Macrophage GTPases in Brucella Killing
-
批准号:7230101
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2006
-
负责人:JAMES CARDELLI
-
依托单位:
HGF Regulated Vesicle Trafficking and Tumor Invasion
-
批准号:6930457
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2004
-
负责人:JAMES CARDELLI
-
依托单位:
HGF Regulated Vesicle Trafficking and Tumor Invasion
-
批准号:6825196
-
项目类别:
-
资助金额:$25.38万
-
财政年份:2004
-
负责人:JAMES CARDELLI
-
依托单位:
HGF Regulated Vesicle Trafficking and Tumor Invasion
-
批准号:7105116
-
项目类别:
-
资助金额:$24.78万
-
财政年份:2004
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING OF LYSOSOMAL ENZYMES
-
批准号:3463120
-
项目类别:
-
资助金额:$6.7万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING OF LYSOSOMAL ENZYMES
-
批准号:3463121
-
项目类别:
-
资助金额:$6.95万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING OF LYSOSOMAL ENZYMES IN DICTYOSTELIUM
-
批准号:2140856
-
项目类别:
-
资助金额:$13.24万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
REGULATION OF PHAGOCYTOSIS
-
批准号:6176472
-
项目类别:
-
资助金额:$18.0万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
REGULATION OF PHAGOCYTOSIS
-
批准号:2905364
-
项目类别:
-
资助金额:$17.49万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING OF LYSOSOMAL ENZYMES IN DICTYOSTELIUM
-
批准号:3239017
-
项目类别:
-
资助金额:$12.3万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING OF LYSOSOMAL ENZYMES IN DICTYOSTELIUM
-
批准号:3239016
-
项目类别:
-
资助金额:$13.09万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING O LYSOSOMAL ENZYMES IN DICTYOSTELIUM DISCOIDEU
-
批准号:3463119
-
项目类别:
-
资助金额:$8.55万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING OF LYSOSOMAL ENZYMES IN DICTYOSTELIUM
-
批准号:2140855
-
项目类别:
-
资助金额:$12.77万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
REGULATION OF PHAGOCYTOSIS
-
批准号:2687571
-
项目类别:
-
资助金额:$16.99万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGETING OF LYSOSOMAL ENZYMES IN DICTYOSTELIUM
-
批准号:2016267
-
项目类别:
-
资助金额:$13.73万
-
财政年份:1988
-
负责人:JAMES CARDELLI
-
依托单位:
TARGET LYSOSOMAL ENZYMES IN DICTYOSTELIUM DISCOIDEUM
-
批准号:3447477
-
项目类别:
-
资助金额:$3.7万
-
财政年份:1986
-
负责人:JAMES CARDELLI
-
依托单位:
海外基金